Xencor
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
465 N Halstead St Ste 200, Pasadena, Cal...Phone Number
(626) 305-5900Website
www.xencor.comRevenue
$105 MillionStock Symbol
XNCRIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Xencor
Xencor, Inc. is a clinical-stage biotechnology company dedicated to the discovery, development, and advancement of engineered antibody and protein therapeutics for the treatment of cancer, autoimmune diseases, inflammatory disorders, and other serious medical conditions. The company focuses on applying its proprietary protein engineering technologies to create innovative biologic medicines with enhanced therapeutic propertiesExplore more
Xencor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xencor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Xencor has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Xencor recently announced quarterly report
Product Launch: Get notified when Xencor launches new products
Click to see if Xencor had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Xencor has new funding data
Check out if Xencor is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Xencor
Xencor, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Xencor
Compare insights from companies similar to Xencor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Xencor
$105M
201-500
Public
$237.2M
1997
CE
Celia EckertSenior Vice President, General Counsel & Corporate Secretary
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Company Profile Activity
Activity Insights
Xencor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xencor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xencor.
Xencor financials insights
Gather financial insights about Xencor, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1999
Series B
$12.3M
2000
Series C
$50M
2005
Series D
$10M
2007
Series E
$60M
2010
Debt
$7.5M
2013
Stock Offering
$72.4M
2021
Share Placement
$25M
Xencor Tech Stack
A closer look at the technologies used by Xencor
See more technologies
Most Recent Scoops
Open Position
Person-Based
Pharmaceuticals
Person-Based
Events, Compliance
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Earnings, Clinical Operations, Finance
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xencor
Sign Up For FreeTo access detailed company insights
Xencor, Inc. is a clinical-stage biotechnology company dedicated to the discovery, development, and advancement of engineered antibody and protein therapeutics for the treatment of cancer, autoimmune diseases, inflammatory disorders, and other serious medical conditions. The company focuses on applying its proprietary protein engineering technologi... Read More
